Premium
Appili Therapeutics Inc (PK) (APLIF)
USOTC
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2023-10-14 | Bloom Burton Investment Group Inc.Société | -1,32M | 0,00 | Other Derivative Disposition | - | 1,19M | -52,57% |
| 2025-06-30 | Mr. Prakash GowdIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 682,00k | 17,18% |
| 2025-06-30 | Dr. Donald D. CillaCEO, President & Director | 75,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,71M | 4,58% |
| 2025-06-30 | Mr. Brian Matthew BloomIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 380,00k | 35,71% |
| 2025-06-30 | Dr. Juergen FroehlichIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,24M | 8,78% |
| 2025-06-30 | Dr. Armand BalboniChairman of the Board | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 2,99M | 3,46% |
| 2025-06-30 | Dr. Theresa MatkovitsLead Independent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,34M | 8,09% |
| 2025-06-30 | Mr. Kenneth G. HowlingActing CFO | 107,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,13M | 10,44% |
| 2025-06-30 | Mr. Prakash GowdIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 682,00k | 17,18% |
| 2025-06-30 | Dr. Donald D. CillaCEO, President & Director | 75,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,71M | 4,58% |
| 2025-06-30 | Mr. Brian Matthew BloomIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 380,00k | 35,71% |
| 2025-06-30 | Dr. Juergen FroehlichIndependent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,24M | 8,78% |
| 2025-06-30 | Dr. Armand BalboniChairman of the Board | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 2,99M | 3,46% |
| 2025-06-30 | Dr. Theresa MatkovitsLead Independent Director | 100,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,34M | 8,09% |
| 2025-06-30 | Mr. Kenneth G. HowlingActing CFO | 107,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,01 | 1,13M | 10,44% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
